Torrent Pharmaceuticals Limited
TORNTPHARM
Rank in Stocks
#1192
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Share Price
$50.50
Market Cap
$19.21B
Change (1 day)
0.23%
Change (1 year)
24.01%
Country
IN
Trade Torrent Pharmaceuticals Limited (TORNTPHARM)
Category
Healthcare
EPS for Torrent Pharmaceuticals Limited (TORNTPHARM)
EPS as of June 2026 TTM: $0.71
According to Torrent Pharmaceuticals Limited latest financial reports and stock price the company's current EPS (TTM) is $0.71. At the end of 2024 the company had a EPS of $0.59 an increase over its 2023 EPS that were of $0.45.
EPS history for Torrent Pharmaceuticals Limited from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.71 | 7.76% |
| 2025 | $0.66 | 12.51% |
| 2024 | $0.59 | 31.09% |
| 2023 | $0.45 | 48.00% |
| 2022 | $0.30 | -40.13% |
| 2021 | $0.51 | 25.73% |
| 2020 | $0.40 | 116.54% |
| 2019 | $0.19 | -39.70% |
| 2018 | $0.31 | -27.64% |
| 2017 | $0.43 | -44.97% |
| 2016 | $0.77 | 117.38% |
| 2015 | $0.36 | 8.68% |
| 2014 | $0.33 | 39.00% |
| 2013 | $0.24 | 42.24% |
| 2012 | $0.17 | -7.59% |
| 2011 | $0.18 | 17.75% |
| 2010 | $0.15 | 41.62% |
| 2009 | $0.11 | 7.94% |
| 2008 | $0.10 | 56.20% |
| 2007 | $0.06 | 89.02% |
| 2006 | $0.03 | 2.12% |
| 2005 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.78% |
IN
|
